Neuberger Berman Group LLC Bristol Myers Squibb CO Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 3,161,052 shares of BMY stock, worth $146 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,161,052
Previous 3,161,052
-0.0%
Holding current value
$146 Million
Previous $146 Million
-0.0%
% of portfolio
0.12%
Previous 0.12%
Shares
35 transactions
Others Institutions Holding BMY
# of Institutions
2,664Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...